Alethios Launches AI Platform to Simplify Human Health Research
Alethios has officially launched its software platform aimed at making structured human health research accessible to a broader range of users, announced in a press release. The platform enables researchers—from biotech companies to citizen scientists—to design and execute studies using integrated data sources including self-reported outcomes, wearable sensors, and at-home biomarker kits.
Founded in 2023 by CEO Zeenia Framroze, Alethios offers two main tools: the Study Planner and Study Operator. The Study Planner allows users to design decentralized studies, digitize existing protocols, and generate recruitment materials in minutes using a generative AI feature called AI QuickStart. The Study Operator automates study logistics, participant management, and reporting through the Alethiad Participant Community.
Researchers can begin with a seven-day free trial and then continue using the platform for $100 per month. According to the company, studies built with Alethios have achieved participant adherence rates above 90% and reduced recruitment timelines to as little as three to four weeks.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
AI’s Time-to-Market Quagmire: Why Enterprises Struggle to Scale AI Innovation
The 2025 AI Governance Benchmark Report by ModelOp provides insights from 100 senior AI and data leaders across various industries, highlighting the challenges enterprises face in scaling AI initiatives. The report emphasizes the importance of AI governance and automation in overcoming fragmented systems and inconsistent practices, showcasing how early adoption correlates with faster deployment and stronger ROI.
Read more